Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • John Snow Labs Announces Inaugural Healthcare NLP Summit in Response to Industry Demand

    Mar 1, 2021, 09:38 AM by
    John Snow Labs announces first-ever Healthcare NLP Summit, being held virtually from April 6-9.
    Full story
  • SeqOnce Biosciences Announces RT-qPCR Assay to Detect SARS-CoV-2 N501Y Variant

    Mar 1, 2021, 09:38 AM by
    SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel coronavirus SARS-CoV-2 N501Y variant. The AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR N501Y kit uses a single-tube reaction targeting the N1 nucleocapsid gene, both alleles of S gene N501Y (A23063T), and includes RNaseP as a control. The assay uses common qPCR instruments with detection channels of FAM, HEX, Cy5, and ROX.
    Full story
  • AARDEX Group and Pill Connect Ltd Partner to Empower Patient Adherence

    Mar 1, 2021, 09:34 AM by
    Full story
  • CloudLIMS Announces Collaboration with Folio for Secure Issuance of COVID-19 Results to Patients

    Mar 1, 2021, 09:34 AM by
    CloudLIMS’ COVID-19 LIMS solution has integrated with Folio's mobile app to enable receiving, storing, and sharing of COVID-19 test results securely and digitally.
    Full story
  • NSTDA-BIOTEC selects Key Organics BIONET Fragment Library to identify new non-pyrimidine inhibitors of malaria parasite Plasmodium falciparum dihydrofolate reductase (PfDHFR).

    Mar 1, 2021, 09:34 AM by
    In recent research at BIOTEC1 a three-step fragment-based screening of PfDHFR was undertaken employing Key Organics BIONET Premium library containing 1163 fragments. This library was chosen over other commercial ones as it is rule-of-three compliant and was curated from any PAINS and aggregating compounds. All fragments are also soluble at 200 mM in DMSO and display high diversity.
    Full story
  • ComputaBio is Capable to provide Drug Design Services

    Mar 1, 2021, 09:32 AM by
    ComputaBio, a US supplier of computational biology services, claims to be a capable helping hand in drug design for industrial and academic scientists worldwide to expedite their drug development projects.
    Full story
  • VisualDx Launches Project IMPACT to Address Racism and Implicit Bias in Medicine

    Mar 1, 2021, 09:32 AM by
    Full story
  • IntelyCare Hires David Burke as CFO to Drive Business Growth and Momentum; Address Intensifying Staffing Demands in Post-Acute Space

    Mar 1, 2021, 09:32 AM by
    IntelyCare hires David Burke as chief financial officer to support the continued success and expansion of the company.
    Full story
  • Alfa Chemistry: T,C&A Lab Unveils Ingredient Analysis Service

    Mar 1, 2021, 09:32 AM by
    Full story
  • KROHNE Features OPTIMASS 1000 Straight Tube Coriolis Mass Meter

    Mar 1, 2021, 09:32 AM by
    KROHNE, Inc. features its OPTIMASS 1000 Straight Tube Coriolis Mass Meter manufactured at its state of the art flow and level instrument manufacturing and calibration facility located in Beverly, MA. OPTIMASS 1000 is designed for exceptional measurement capabilities with the flexibility and options of high-end meters, at a competitive price. The OPTIMASS 1000 is well-suited for a variety of industries, including the chemical, petrochemical, food and beverage, water and pharmaceutical, and can operate reliably between -40 and 130° C.
    Full story
  • Creative Biostructure Performs Comprehensive Lead Discovery and Optimization Solutions

    Mar 1, 2021, 09:32 AM by
    Full story
  • KCR opens new branch in Sydney, Australia

    Mar 1, 2021, 09:32 AM by
    KCR, the international clinical development solutions provider, today announced the establishment of a new branch in Sydney, Australia. The new location will enhance KCR’s regional coverage and maximize clinical capabilities for clients across the globe.
    Full story
  • BOC Sciences Strengthens the Cooperation with Global Biotechnology Companies to Promote ADCs Development & Research

    Mar 1, 2021, 09:32 AM by
    Full story
  • Pfannenberg Datawind Filterfans® Cool in IT Environments without Sacrificing Valuable Rack Space

    Mar 1, 2021, 09:28 AM by
    Purpose-built product is ideal for space-restricted and manufacturing floor IT installations
    Full story
  • Rousselot Biomedical joins European ENLIGHT project to develop a 3D living model of pancreatic tissue

    Mar 1, 2021, 09:28 AM by
    In the European project ENLIGHT, researchers from academic centers and leading industries across Europe are joining forces to develop a living model of the pancreas to enable better testing of diabetes medication.
    Full story
  • MedAI Releases Drug Formulation Development Service for the Pharmaceutical Industry

    Mar 1, 2021, 09:28 AM by
    Full story
  • CellPort Software Announces Release of CellPort Cell Culture Suite

    Mar 1, 2021, 09:28 AM by
    CellPort Software today announced the launch of the CellPort Cell Culture Suite, a new cloud-based Software as a Service (SaaS) product focused on cell culture and cell banking. CellPort Cell Culture Suite is a secure, compliant SaaS-based application suite focused on managing all lab workflows, activities, equipment, materials, personnel, data/calculations, locations, and projects for cell culture and cell banking. CellPort reduces errors, increases reproducibility, enhances productivity, and provides full audit-ready traceability for regulated and unregulated environments.
    Full story
  • Study Shows Biocept’s Target Selector™ Detects Mutations in “Quantity Not Sufficient” Specimens in Non-Small Cell Lung Cancer Patients

    Mar 1, 2021, 09:28 AM by
    Biocept presents data showing its Target Selector molecular assay kit detects mutations in up to 50% of tissue biopsy specimens, from patients diagnosed with non-small cell lung cancer, that were deemed quantity not sufficient (QNS).
    Full story
  • Healthtech company Raremark® reboots as XperiomeTM to drive increased value for rare disease patients and researchers

    Mar 1, 2021, 09:28 AM by
    Full story
  • PHARMASEAL’s Engility® platform fights off competition to be selected by award-winning US Medical Device company

    Mar 1, 2021, 09:28 AM by
    Full story
  • «
  • 181
  • 182
  • 183
  • 184 (current)
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy